FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly CBS NewsApproval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment The Wall Street JournalFDA Approves Second Alzheimer’s Drug after Promising Trial The Daily BeastFDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease CNNFDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s The New York Times